We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$66.2M
AUM Growth
-$4.96M
Cap. Flow
-$354K
Cap. Flow %
-0.53%
Top 10 Hldgs %
43.96%
Holding
112
New
26
Increased
20
Reduced
20
Closed
42
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.62M
2
PFE icon
Pfizer
PFE
+$3.09M
3
GILD icon
Gilead Sciences
GILD
+$2.52M
4
UNH icon
UnitedHealth
UNH
+$2.44M
5
LLY icon
Eli Lilly
LLY
+$1.85M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$1.61M
2
THC icon
Tenet Healthcare
THC
+$1.3M
3
AAPL icon
Apple
AAPL
+$1.26M
4
BRCM
BROADCOM CORP CL-A
BRCM
+$1.13M
5
LBTYK icon
Liberty Global Class C
LBTYK
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 69%
2 Communication Services 5.62%
3 Financials 5.54%
4 Technology 4.38%
5 Consumer Discretionary 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$4.35M 6.57%
47,279
+305
+0.6% +$26.4K
2013 Q2
9 quarters
HCA icon
2
HCA Healthcare
HCA
$101B
$3.6M 5.45%
46,572
+8,970
+24% +$794K
2013 Q2
9 quarters
WBA icon
3
DELISTED
Walgreens Boots Alliance
WBA
$3.47M 5.25%
41,793
+12,427
+42% +$1.12M
2014 Q4
3 quarters
UNH icon
4
UnitedHealth
UNH
$365B
$3.31M 5%
28,505
+20,353
+250% +$2.44M
2014 Q4
3 quarters
AGN
5
DELISTED
Allergan plc
AGN
$3.2M 4.84%
+11,785
New +$3.62M
2015 Q3
0 quarters
PFE icon
6
Pfizer
PFE
$168B
$2.87M 4.34%
+96,289
New +$3.09M
2015 Q3
0 quarters
GILD icon
7
Gilead Sciences
GILD
$195B
$2.23M 3.37%
+22,683
New +$2.52M
2015 Q3
0 quarters
EW icon
8
Edwards Lifesciences
EW
$50.8B
$2.16M 3.27%
91,212
-7,740
-8% -$187K
2014 Q4
3 quarters
BMY icon
9
Bristol-Myers Squibb
BMY
$124B
$2.05M 3.1%
34,643
-1,499
-4% -$95.1K
2015 Q1
2 quarters
LLY icon
10
Eli Lilly
LLY
$1.12T
$1.84M 2.78%
+21,964
New +$1.85M
2015 Q3
0 quarters
TEVA icon
11
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$1.71M 2.58%
30,192
+5,051
+20% +$328K
2014 Q1
6 quarters
META icon
12
Meta Platforms (Facebook)
META
$1.88T
$1.62M 2.45%
18,039
+2,182
+14% +$200K
2013 Q4
7 quarters
PANW icon
13
Palo Alto Networks
PANW
$303B
$1.53M 2.32%
53,460
+16,146
+43% +$476K
2014 Q2
5 quarters
AET
14
DELISTED
Aetna Inc
AET
$1.52M 2.3%
13,890
-500
-3% -$57.8K
2015 Q2
1 quarter
MDCO
15
DELISTED
Medicines Co
MDCO
$1.38M 2.09%
36,399
-1,111
-3% -$39K
2015 Q2
1 quarter
UHS icon
16
Universal Health Services
UHS
$11B
$1.37M 2.07%
10,993
+1,005
+10% +$140K
2015 Q2
1 quarter
VMC icon
17
Vulcan Materials
VMC
$32.7B
$1.37M 2.07%
15,344
-4,480
-23% -$417K
2014 Q1
6 quarters
AER icon
18
AerCap
AER
$22.9B
$1.32M 2%
34,563
-14,621
-30% -$646K
2015 Q1
2 quarters
HRTX icon
19
Heron Therapeutics
HRTX
$71.5M
$1.27M 1.92%
51,947
+22,542
+77% +$751K
2015 Q2
1 quarter
NOW icon
20
ServiceNow
NOW
$154B
$1.14M 1.73%
82,320
+24,305
+42% +$363K
2015 Q2
1 quarter
JAZZ icon
21
Jazz Pharmaceuticals
JAZZ
$13.9B
$1.08M 1.63%
8,136
-777
-9% -$134K
2015 Q1
2 quarters
BRCM
22
DELISTED
BROADCOM CORP CL-A
BRCM
$1.08M 1.63%
20,985
-22,025
-51% -$1.13M
2014 Q4
3 quarters
HD icon
23
Home Depot
HD
$308B
$1M 1.52%
+8,695
New +$1.01M
2015 Q3
0 quarters
MIC icon
24
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$984K 1.49%
13,177
-4,164
-24% -$332K
2014 Q1
6 quarters
HOLX icon
25
DELISTED
Hologic
HOLX
$975K 1.47%
24,910
-8,492
-25% -$337K
2014 Q3
4 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2015 Portfolio in Review

As of Q3 2015, Partner Investment Management held 112 positions worth $66.2M, down 7% from $71.1M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Partner Investment Management's Q3 2015 filing shows 26 new, 20 increased, 20 reduced and 42 closed positions. Its largest new stake was Allergan plc: 11,785 shares worth $3.2M. The largest sale was Elevance Health, an estimated $1.61M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, up from 57% a quarter earlier, followed by Communication Services and Financials.

  • Partner Investment Management's largest Q3 2015 buy was Allergan plc: 11,785 shares worth $3.2M.
  • Partner Investment Management added most to UnitedHealth in Q3 2015, an estimated $2.44M increase.
  • Partner Investment Management's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $1.13M.
  • Partner Investment Management fully exited Elevance Health in Q3 2015, selling an estimated $1.61M.
  • Partner Investment Management's ten largest holdings make up 44% of its $66.2M portfolio in Q3 2015.
  • Partner Investment Management opened 26 new positions and closed 42 in Q3 2015.
  • Partner Investment Management's portfolio value fell 7% quarter-over-quarter to $66.2M.

Based on Partner Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.